Trial NCT00448539

View at ClinicalTrials.gov 
Org. Study IDs: E2080-A001-302
Secondary IDs: 2016-004950-14

Last trial update was posted on 2019-11-22

MeSH Interventions

Rufinamide

MeSH Conditions

Seizures

Other Conditions

Refractory Partial Onset Seizures

Stopping Reasons

The study was terminated early by the sponsor due to the discontinuation of clinical development for rufinamide.

Limitations And Caveats

This study was terminated early by the sponsor due to the discontinuation of clinical development for rufinamide.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID